Overview

  • Product nameAnti-RFX5 antibody (Agarose)
    See all RFX5 primary antibodies
  • Description
    Rabbit polyclonal to RFX5 (Agarose)
  • ConjugationAgarose
  • Tested applicationsSuitable for: IPmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Immunogen was a synthetic peptide, which represented a portion of Human Regulatory Factor X 5 encoded within exon 5.

Properties

  • FormLiquid
  • Storage instructionsShipped at 4°C. Store at +4°C.
  • Storage bufferPreservative: 0.1% Sodium Azide
    Constituents: 0.1M Sodium chloride, 0.01M PBS, pH 7.2
  • Concentration information loading...
  • PurityImmunogen affinity purified
  • Purification notesSupplied as 400 µl of 50% slurry containing 200 µl agarose. Antibody was affinity purified using the peptide immobilized on solid support. Rabbit anti-human RFX5 affinity purified antibodies were coupled to agarose beads using a cyanogen bromide method.
  • ClonalityPolyclonal
  • IsotypeIgG
  • Research areas

Applications

Our Abpromise guarantee covers the use of ab19199 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
IP
  • Application notesImmunoprecipitation: 15 to 25 µl of gel slurry per 0.1 to 1 mg of protein lysate or extract.

    Not tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • FunctionActivates transcription from class II MHC promoters. Recognizes X-boxes. Mediates cooperative binding between RFX and NF-Y. RFX binds the X1 box of MHC-II promoters.
    • Tissue specificityUbiquitous.
    • Involvement in diseaseDefects in RFX5 are a cause of bare lymphocyte syndrome type 2 (BLS2) [MIM:209920]; also known as hereditary MHC class II deficiency or HLA class II-deficient combined immunodeficiency. BLS2 is a severe combined immunodeficiency disease with early onset. It is characterized by a profound defect in constitutive and interferon-gamma induced MHC II expression, absence of cellular and humoral T-cell response to antigen challenge, hypogammaglobulinemia and impaired antibody production. The consequence include extreme susceptibility to viral, bacterial and fungal infections.
    • Sequence similaritiesBelongs to the RFX family.
      Contains 1 RFX-type winged-helix DNA-binding domain.
    • DomainThe N-terminus is required for dimer formation, association with RFXANK and RFXAP, assembly of the RFX complex, and for binding of this complex to its X box target site in the MHC-II promoter. The C-terminus mediates cooperative binding between the RFX complex and NF-Y.
    • Post-translational
      modifications
      Phosphorylated.
    • Cellular localizationNucleus.
    • Information by UniProt
    • Database links
    • Alternative names
      • DNA binding protein RFX 5 antibody
      • DNA binding protein RFX5 antibody
      • DNA-binding protein RFX5 antibody
      • Influences HLA class II expression antibody
      • Regulatory factor X 5 antibody
      • Regulatory factor X subunit 5 antibody
      • Regulatory factor X, 5 (influences HLA class II expression) antibody
      • RFX 5 antibody
      • RFX5 antibody
      • Rfx5 protein antibody
      • RFX5_HUMAN antibody
      see all

    References for Anti-RFX5 antibody (Agarose) (ab19199)

    ab19199 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab19199.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"